# ctDNA Assessment in Endometrial Cancer for Adjuvant Therapy

> **NCT07681414** · — · ACTIVE_NOT_RECRUITING · sponsor: **Guizhou Provincial People's Hospital** · enrollment: 52 (actual)

## Conditions studied

- Endometrial Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07681414
- **Lead sponsor:** Guizhou Provincial People's Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2026-06-27
- **Primary completion:** 2026-12-31
- **Final completion:** 2026-12-31
- **Target enrollment:** 52 (ACTUAL)
- **Last updated:** 2026-07-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07681414

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07681414, "ctDNA Assessment in Endometrial Cancer for Adjuvant Therapy". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07681414. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*